Skip to main content
HCA
NYSE Industrial Applications And Services

HCA 10-Q Details Q3 Earnings: $1.579B Net Income, Uncompensated Care Up 24%

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare Facility Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$478.08
Mkt Cap
$103.505B
52W Low
$353.99
52W High
$556.52
52W Position info
35% above low
Off High info
14% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

HCA sits 35% above its 52-week low of $353.99.

Summary

HCA's Q3 10-Q confirms the $19.849 billion revenue and $7.27 diluted EPS already reported, while showing uncompensated care costs up 24% and nine-month operating cash flow down $1.467 billion.


Key Events · Earnings and Guidance · HCA

  • Q3 Results Confirmed in Full Filing

    Revenue $19.849 billion (+3.6%) and diluted EPS $7.27 vs $6.96 a year ago; nine-month revenue $59.188 billion (+5.5%) and diluted EPS $22.05.

  • Uncompensated Care Costs Jump

    Estimated cost of total uncompensated care was $1.477 billion in Q3 vs $1.188 billion a year ago, and $4.174 billion for nine months vs $3.359 billion, as uninsured admissions rose 27.2%.

  • Operating Cash Flow Falls $1.467 Billion

    Nine-month operating cash flow was $8.810 billion vs $10.277 billion, driven by $1.190 billion more in income taxes paid and $472 million of unfavorable working capital.

  • Debt Rises to $50.493 Billion

    Total debt increased from $46.492 billion at December 31, 2025, with commercial paper at $5.727 billion vs $2.207 billion; the CPP was upsized to $8.000 billion in July 2026.


Analysis · HCA · Industrial Applications And Services

The headline numbers were already out on October 27, but the full 10-Q fills in the parts that matter for the thesis. Uncompensated care cost jumped to $1.477 billion in Q3 from $1.188 billion a year ago as uninsured admissions rose 27.2%. Nine-month operating cash flow fell to $8.810 billion from $10.277 billion, largely on $1.190 billion more in income tax payments. Debt also climbed to $50.493 billion from $46.492 billion at year-end, with commercial paper up to $5.727 billion. The company is still buying back stock aggressively — 7.2 million shares in Q3 at an average $410.85 — leaving $4.240 billion of authorization.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 37.5% of the 3713 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, HCA was trading at $478.08 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $103.5B. The 52-week trading range was $353.99 to $556.52. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

HCA - Latest Insights

HCA
Nov 09, 2026, 6:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $499.00
Real-time Price: $510.37 info
Change: +$11.37 (+2%) info
Market Cap: $106.542B info
HCA
Oct 27, 2026, 1:11 PM EDT
Source: Benzinga
Importance Score:
8
Price at Filing: $443.28
Real-time Price: $510.37 info
Change: +$67.09 (+15%) info
Market Cap: $106.542B info
HCA
Oct 27, 2026, 7:17 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $485.00
Real-time Price: $510.37 info
Change: +$25.37 (+5%) info
Market Cap: $106.542B info
HCA
Oct 27, 2026, 7:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $460.95
Real-time Price: $510.37 info
Change: +$49.42 (+11%) info
Market Cap: $106.542B info
HCA
Sep 15, 2026, 8:30 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $423.00
Real-time Price: $510.37 info
Change: +$87.37 (+21%) info
Market Cap: $106.542B info